Trials / Conditions / Select Advanced Solid Tumors
Select Advanced Solid Tumors
6 registered clinical trials studyying Select Advanced Solid Tumors — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encod NCT06598371 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Recruiting | First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors NCT06402201 | CDR-Life AG | Phase 1 |
| Active Not Recruiting | Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors NCT04262466 | Immunocore Ltd | Phase 1 / Phase 2 |
| Withdrawn | Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab NCT03973333 | Immunocore Ltd | Phase 1 / Phase 2 |
| Terminated | Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers NCT03515551 | Immunocore Ltd | Phase 1 / Phase 2 |
| Completed | A Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Sol NCT02705482 | MedImmune LLC | Phase 1 |